Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch & Lomb CorpBLCO · Entity 3756 | Please see remarks | March 01, 2023 | March 03, 2023 |
| Bausch Health Companies Inc.BHC · Entity 4363 | Pres&Co-Head Bausch&Lomb/Int'l | March 08, 2022 | March 10, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch & Lomb Corp
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 125,702 |
Reported balance
After 2023-03-01 transaction · row 1
1 source rowRow 1 · 2023-03-01 · Grant · Acquired 21,258 · Balance 125,702 F1: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. |
| Non-Qualified Stock Options (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $17.96 | Direct | 68,058 |
Reported balance
After 2023-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-01 · Grant · Acquired 68,058 · Balance 68,058 F2: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F3: The stock options will expire on the tenth anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation.
F2: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
F3: The stock options will expire on the tenth anniversary of the grant date.
Bausch Health Companies Inc.
Report date March 08, 2022 · Filed March 10, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 93,139 |
Reported balance
After 2022-03-08 transaction · row 1
1 source rowRow 1 · 2022-03-08 · Sale · Disposed 3,889 · Balance 93,139 F1: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 68,058 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001127602-23-008778 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,058 Underlying: Common Shares, No Par Value · 68,058 shares Expires not disclosed F2 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F3 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 21,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008778 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,702 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 23:41 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019826 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,444 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation. Read SEC document |
| May 05, 2022 Filed May 9, 2022 22:46 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 274,725 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017323 · doc4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,725 Underlying: Common Shares, No Par Value · 274,725 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase Common Shares under the Plan. F3 · derivative.exercise_date: The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement. F4 · derivative.expiration_date: The stock options will expire on the tenth anniversary of the grant date. Read SEC document |
| May 05, 2022 Filed May 9, 2022 22:46 UTC | Bausch & Lomb Corp BLCO · Entity 3756 | GrantCommon Shares, No Par Value | 69,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017323 · doc4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Please see remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,444 F1 · shares: Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan"). Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation (the "Company"). Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:03 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 3,889 | $21.76 | $84,624.64 |
DisclosureSEC source: 0001127602-22-008873 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,139 F1 · shares: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 22:32 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 4,074 | $23.61 | $96,187.14 |
DisclosureSEC source: 0001127602-22-008485 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,028 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 11,077 | $23.37 | $258,869.49 |
DisclosureSEC source: 0001127602-22-008299 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,102 F1 · shares: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 6,338 | $23.82 | $150,971.16 |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · nonDerivative · entry 5 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,179 F6 · shares: The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 17,350 | $24.35 Strike: $24.35 | $422,472.50 |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · derivative · entry 7 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 0 shares Expires 2022-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantRestricted Share Units · Derivative | 17,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · derivative · entry 6 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 17,350 shares Expires 2022-02-27 F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis F2 · price: Each PSU converts into Common Shares on a one-for-one basis F1 · derivative.exercise_date: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,716 | $24.35 | $41,784.60 |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · nonDerivative · entry 4 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,517 F5 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 6,233 | $24.35 | $151,773.55 |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · nonDerivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,755 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. Read SEC document |
| February 27, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 17,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer. F2 · price: Each PSU converts into Common Shares on a one-for-one basis Read SEC document |
| February 26, 2022 Filed Mar 3, 2022 02:29 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,522 | $24.35 | $37,060.70 |
DisclosureSEC source: 0000899243-22-008830 · doc4.xml · nonDerivative · entry 3 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,233 F4 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs"). Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 01:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 12,461 | $32.97 | $410,839.17 |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 3 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,638 F3 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 5,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · derivative · entry 4 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 5,637 shares Expires 2021-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. F4 · derivative.exercise_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F4 · derivative.expiration_date: The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 3 filed on August 10, 2018 with the target potential award amount of 4,546 shares. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 17,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,099 F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 01:55 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 5,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-010164 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018. F2 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:57 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 32,749 | $0.00 Strike: $32.56 | $0.00 |
DisclosureSEC source: 0001127602-21-009564 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,749 Underlying: Common Shares, No Par Value · 32,749 shares Expires 2031-03-03 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:57 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 23,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009564 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,142 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,313 | $31.42 | $104,094.46 |
DisclosureSEC source: 0001127602-21-009196 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,250 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 00:59 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,239 | $20.96 | $46,929.44 |
DisclosureSEC source: 0001127602-20-010327 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,563 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:22 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,499 | $24.44 | $61,075.56 |
DisclosureSEC source: 0001127602-20-009133 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,802 F1 · shares: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 56,858 | $0.00 Strike: $24.77 | $0.00 |
DisclosureSEC source: 0001127602-20-008448 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,858 Underlying: Common Shares, No Par Value · 56,858 shares Expires 2030-02-26 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 00:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 13,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-008448 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,301 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| February 20, 2020 Filed Feb 22, 2020 02:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 11,703 | $26.46 | $309,661.38 |
DisclosureSEC source: 0001127602-20-007081 · form4.xml · nonDerivative · entry 3 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,795 F4 · kind: This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionRestricted Share Units · Derivative | 5,242 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-007081 · form4.xml · derivative · entry 4 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, No Par Value · 5,242 shares Expires 2020-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PSU converts into Common Shares on a one-for-one basis. F3 · price: Each PSU converts into Common Shares on a one-for-one basis. F2 · derivative.exercise_date: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F2 · derivative.expiration_date: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F5 · balance_after: This PSU award was previously reported on a Form 3 filed on August 10, 2018 with the target award amount of 5,461 shares. Any portion of the award not vested on February 19, 2020 was cancelled as of that date. Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 28,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007081 · form4.xml · nonDerivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,498 Read SEC document |
| February 19, 2020 Filed Feb 22, 2020 02:58 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Exercise / conversionCommon Shares, No Par Value | 5,242 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-007081 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person in connection with the vesting of performance-based Restricted Share Units ("PSUs") granted to the reporting person on January 6, 2017. F2 · shares: On January 6, 2017, the reporting person was granted PSUs that were distributed on February 19, 2020 following certification of the achievement of certain performance metrics. F3 · price: Each PSU converts into Common Shares on a one-for-one basis. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 21:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,118 | $29.42 | $62,311.56 |
DisclosureSEC source: 0001127602-20-001372 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,078 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| May 06, 2019 Filed May 8, 2019 20:25 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 693 | $23.51 | $16,292.43 |
DisclosureSEC source: 0001127602-19-017751 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,196 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 08, 2019 Filed Mar 12, 2019 20:28 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,557 | $23.56 | $36,682.92 |
DisclosureSEC source: 0001127602-19-011034 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,889 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-qualified Stock Options (right To Purchase) · Derivative | 44,290 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001127602-19-009243 · form4.xml · derivative · entry 2 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,290 Underlying: Common Shares, No Par Value · 44,290 shares Expires 2029-02-27 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 22:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 15,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-009243 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,446 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch Health Companies Inc. ("Bausch Health"). Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 21:10 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,169 | $21.25 | $46,091.25 |
DisclosureSEC source: 0001127602-19-001765 · form4.xml · nonDerivative · entry 1 Gordon Joseph F · CIK 0001749876 · Pres&Co-Head Bausch&Lomb/Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,225 F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.